U.S. Gas Utilities Stock News

Phibro Animal Health (PAHC) just posted its Q3 2026 scorecard with revenue of US$383.5 million and basic EPS of US$0.59, while trailing 12 month revenue stands at US$1.5 billion and EPS at US$2.35, underpinned by trailing 12 month net income of US$95.2 million. The company has seen quarterly revenue move from US$309.3 million in Q2 2025 to US$383.5 million in Q3 2026, with basic EPS shifting from US$0.08 to US$0.59 over the same stretch. This release offers a check-in on how far margins have...

If you are wondering whether Cummins at around US$682.88 is still offering value after a strong run, this article focuses squarely on what the current price might be implying. The stock has posted returns of 1.8% over the last 7 days, 22.6% over the last 30 days, 30.8% year to date, 127.0% over 1 year, 237.0% over 3 years and 192.6% over 5 years, which naturally raises questions about what is already priced in. Recent coverage has highlighted Cummins as a key player in capital goods, with...

Aon (AON) is back in focus after reporting Q1 2026 results that exceeded expectations, reaffirming guidance and highlighting commercial risk strength, AI driven tools, active buybacks, and disciplined capital deployment. See our latest analysis for Aon. Aon’s latest Q1 beat and active buyback have come against a softer share price backdrop. The 90 day share price return shows an 8.32% decline and the 1 year total shareholder return shows an 11.39% decline, suggesting recent momentum has faded...

Rosen Law Firm has opened a securities investigation into DNOW Inc. over potentially misleading business information. The firm is encouraging shareholders of NYSE:DNOW to assess potential legal options in light of the review. This legal development sits outside routine earnings or operational updates and focuses on the company’s disclosures. For investors following NYSE:DNOW, this investigation arrives with the stock trading at around $13.05 and showing mixed recent performance, including a...

In recent months, Penguin Solutions reported stronger quarterly results, raised its fiscal 2026 net sales growth outlook on AI-related demand, and saw insider share sales executed under pre-arranged Rule 10b5-1 plans. These developments highlight a company benefiting from AI infrastructure momentum while still contending with weaker long-term revenue trends, thinner margins, and mixed analyst views on its prospects relative to peers. With Penguin lifting its growth outlook on robust AI...

agilon health (AGL) opened 2026 with Q1 revenue of US$1.4b and basic EPS of US$1.80, alongside net income from continuing operations of about US$10.9m and earnings from discontinued operations of US$19m. The company has seen quarterly revenue fluctuate around the US$1.4b to US$1.6b range since early 2024, while trailing 12 month EPS sits at a loss of US$22.53 on net income from continuing operations of US$373.5m. This puts the spotlight firmly on how sustainably these latest margins have been...

Vanda Pharmaceuticals (VNDA) opened Q1 2026 with total revenue of US$51.7 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$217.8 million and a basic EPS loss of US$4.05. Over recent quarters the company has seen revenue move in a tight band between US$50.0 million and US$57.2 million and quarterly basic EPS losses range from US$0.08 to US$2.39. The latest figures fit into a pattern of steady sales alongside widening losses at the bottom line. For...

Rigetti Computing (RGTI) is back in focus after launching its 108-qubit Cepheus-1-108Q system on its own cloud and Amazon Braket, and investors are watching upcoming earnings for signs of commercial traction. See our latest analysis for Rigetti Computing. The recent launch of Cepheus-1-108Q and growing earnings expectations sit against a mixed price picture, with a 32.51% 1 month share price return but a 22.29% year to date share price decline. At the same time, the 1 year total shareholder...

Spire (SR) has just posted its Q2 2026 numbers, with revenue of US$1.0b and basic EPS of US$3.81. This comes against a backdrop where earnings over the past year grew 31.2% and net margin moved from 9.8% to 12%. Over recent quarters the company has seen revenue move from US$1.05b in Q2 2025 to US$1.0b in Q2 2026, while quarterly EPS shifted from US$3.52 to US$3.81. This sets the scene for a results season where investors are weighing stronger profitability against more moderate earnings...

ANI Pharmaceuticals, Inc. reported its Q1 2026 results and hosted its earnings call on May 8, 2026, after pre-announcing the timing in April. Analysts had expected earnings per share of US$1.28 and modest year-on-year revenue growth, with recent upward estimate revisions adding to attention on the quarter. We’ll now examine how the upcoming Q1 2026 earnings release and recent estimate revisions might influence ANI Pharmaceuticals’ investment narrative. We've uncovered the 12 dividend...

NerdWallet (NRDS) Q1 2026 earnings snapshot NerdWallet (NRDS) opened 2026 with Q1 revenue of US$222.2 million and basic EPS of US$0.30, as trailing twelve month revenue reached US$849.6 million and EPS came in at US$0.95, underpinned by a net profit margin of 8.1% versus 4% in the prior year. Over recent periods, the company has seen quarterly revenue move from US$209.2 million in Q1 2025 to US$225.4 million in Q4 2025 and US$222.2 million in Q1 2026. Basic EPS tracked from roughly flat at...

Starwood Property Trust (STWD) is back in focus after announcing a US$400 million share buyback and maintaining its quarterly dividend, even as tighter coverage follows a recent dilutive acquisition and sector wide headwinds. See our latest analysis for Starwood Property Trust. The share price is at US$18.05, with a 4.58% 1 month share price return contrasting with a small decline year to date, while the 1 year total shareholder return of 5.02% and 3 year total shareholder return of 48.81%...

Stryker (SYK) is back in focus after a March 2026 cyberattack disrupted operations and contributed to missed first quarter revenue and earnings expectations, even as management reiterated full year guidance and recovery plans. See our latest analysis for Stryker. The share price has pulled back to $294.23, with a 30 day share price return of 11.4% and a year to date share price return showing a 15.49% decline. The 5 year total shareholder return of 25.01% contrasts with the weaker 1 year...

Wondering if Federal Home Loan Mortgage at around US$7.14 is a bargain or already pricing in the key positives? This article breaks down what the current price might be implying about the stock. The stock has returned 0.6% over the last week and 26.4% over the past month, while the year-to-date return is a 31.0% decline and the 1-year return sits at 31.7%. Over the past 3 years the share price move has been very large relative to the starting point, and the 5-year return of 243.3% means...

Essential Utilities (WTRG) opened 2026 with Q1 revenue of US$861.8 million and basic EPS of US$0.79, against a backdrop where trailing 12 month revenue stood at about US$2.6 billion and EPS was US$1.97, alongside a clear step down in earnings over the most recent year. The company has seen quarterly revenue move from US$783.6 million in Q1 2025 to US$861.8 million in Q1 2026, while basic EPS shifted from US$1.03 to US$0.79 over the same period, presenting a picture in which investors are...

Why Palladyne AI stock is back in focus Palladyne AI (PDYN) has drawn fresh attention after reaffirming its 2026 revenue outlook of US$24 million to US$27 million and reporting first quarter 2026 results, including sales of US$3.54 million and a net loss of US$12.61 million. See our latest analysis for Palladyne AI. The reaffirmed 2026 guidance and first quarter revenue update come after a mixed price pattern, with a 1-day share price return of 4.8% decline, a 90-day share price return of...

Q1 2026 results set the stage Sturm Ruger (RGR) has opened 2026 with Q1 revenue of US$141.4 million and basic EPS of roughly US$0.01, against a backdrop where the trailing twelve months show a basic EPS loss of US$0.75 on revenue of US$551.7 million. The company has seen quarterly revenue range from US$126.8 million to US$151.1 million over the past year, while basic EPS has swung from a profit of US$0.63 in late 2024 to a quarterly loss of US$1.05 in 2025 and back to a small profit in Q1...

AAON (AAON) opened Q1 2026 with total revenue of US$496.9 million and basic EPS of US$0.49, alongside net income of US$39.8 million, with the stock trading around US$129.25. Over recent quarters the company has seen revenue move from US$297.7 million in Q4 2024 to US$322.1 million in Q1 2025 and then to US$496.9 million in Q1 2026. Over the same period, basic EPS went from US$0.30 to US$0.36 and now US$0.49. These figures frame a results season in which investors will likely focus on how...

Regal Rexnord (RRX) opened Q1 2026 with total revenue of US$1.48 billion, basic EPS of US$0.97 and net income of US$64.3 million, setting the tone for how the business is starting the year. Over the past year, the company has seen revenue move from US$6.03 billion to US$6.00 billion on a trailing basis while trailing EPS has shifted from US$2.95 to US$4.32 and net income from US$196.2 million to US$286.5 million, giving investors a clearer read on how earnings are tracking against a...

Vir Biotechnology (VIR) opened Q1 2026 with essentially flat total revenue at about US$0 million and a basic EPS loss of US$0.85, alongside net income excluding extra items of a US$125.7 million loss. This put the latest quarterly performance firmly in loss making territory. Over recent periods the company has seen quarterly revenue move from US$12.4 million in Q4 2024 to US$3.0 million in Q1 2025, US$1.2 million in Q2 2025, US$0.2 million in Q3 2025, US$64.1 million in Q4 2025 and back to...

Vericel (VCEL) opened Q1 2026 with total revenue of US$68.4 million and a basic EPS loss of US$0.12, setting a clear focal point for how the market reads its latest update. Over recent periods the company has seen revenue move from US$52.6 million in Q1 2025 to US$68.4 million in Q1 2026, while basic EPS shifted from a loss of US$0.23 to a smaller loss of US$0.12, giving investors a clean read on how top line scale and earnings per share are tracking into this new quarter. Against that...

Radware (RDWR) opened Q1 2026 with revenue of US$79.8 million and basic EPS of US$0.14, while earnings from discontinued operations were a loss of US$2.6 million. The company reported quarterly revenue increasing from US$72.1 million and EPS of US$0.10 in Q1 2025 to a range of roughly US$74 million to US$80 million and EPS between US$0.10 and US$0.14 from Q2 to Q4 2025. Over the same period, trailing 12 month earnings grew by 70.5%, and net margin improved from 4.1% to 6.4%. That combination...

MasterCraft Boat Holdings (MCFT) reported Q3 2026 revenue of about US$78.2 million with a basic EPS loss of roughly US$0.04, while net income from continuing operations was a loss of around US$0.7 million. The company has seen quarterly revenue move from about US$75.9 million in Q3 2025 to US$79.5 million in Q4 2025, then to US$69.0 million in Q1 2026, US$71.8 million in Q2 2026 and now US$78.2 million. EPS over that stretch ranged from US$0.23 to US$0.33 in 2025 and from US$0.23 to a small...

Initial context for Immunome stock Immunome (IMNM) has attracted fresh attention after recent share price swings, with the stock now around US$22.19 and a market value near US$2.64b. This has prompted investors to reassess how current fundamentals line up with expectations. See our latest analysis for Immunome. Recent trading has been choppy, with a 1 day share price return of a 4.64% decline and a 7 day share price return of a 3.27% decline. However, the 1 year total shareholder return of...